Zoe Biosciences
PrivateLast Round
Seed
Mar 31, 2023
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Zoe Biosciences operates in Healthcare & Life Sciences and is based in Los Angeles, California. Its latest recorded funding round was a Seed round in March 2023.
Zoe Biosciences is a biotechnology company developing best-in-class therapies to treat cardiometabolic disease by targeting molecular pathways linked to cellular senescence and metabolic dysfunction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zoe Biosciences Comparables
Compare Zoe Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rubedo Life Sciences | 74% | |
| Anodyne Nanotech | 73% | |
| BioAge Labs | 73% |
For institutional investors. Book with your work email.
Zoe Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Zoe Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longevitytech.fund | Pre Seed |
| VitaDAO | Seed |
| Healthspan Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 41% MoM, reaching 1.6K.
- Mar 2, 2026
Monthly visitors grew 192% MoM, reaching 1.2K.
For institutional investors. Book with your work email.
Zoe Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Zoe Biosciences's valuation, stock price, and market status.
Is Zoe Biosciences a public or private company?
Zoe Biosciences is a private company.
What is the current stock price of Zoe Biosciences?
Zoe Biosciences is a private company, so its shares have no public market price. Caplight tracks Zoe Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Zoe Biosciences worth (valuation)?
Valuation information for Zoe Biosciences is not publicly available.
Can I buy Zoe Biosciences stock?
Zoe Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Zoe Biosciences's last funding round?
Zoe Biosciences's most recent funding round was Seed on March 31, 2023.
Who are the main investors in Zoe Biosciences?
Key investors in Zoe Biosciences include Longevitytech.fund, VitaDAO, Healthspan Capital.
Will Zoe Biosciences IPO soon?
No public IPO plans have been announced for Zoe Biosciences.
How can I track Zoe Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Zoe Biosciences's shares on secondary markets.